SCHEMBL473445

SCHEMBL473445

Cc1cc(CN2CCN(c3ncnc4[nH]nc(Br)c34)CC2)ccc1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
RAB9A P51151 1/20 0.39
PPARG P37231 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
CSF1R P07333 1/20 0.39
LIMK2 P53671 4/20 0.38
RPS6KB1 P23443 2/20 0.38
AKT1 P31749 5/20 0.38
LMNA P02545 2/20 0.38
AKT1S1 Q96B36 1/20 0.38
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
FAAH O00519 1/20 0.37
MAPT P10636 2/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
POLB P06746 1/20 0.37
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3032138 0.86 AKT1 (0.43) MEN1KMT2ACSF1RAKT1KDM4E
SCHEMBL473291 0.82 CHKA (0.46) MEN1KMT2ALIMK2RPS6KB1AKT1
SCHEMBL10159430 0.81 CSF1R (0.43) MEN1KMT2ACSF1RAKT1LMNA
SCHEMBL4923498 0.81 LIMK2 (0.41) LIMK2RPS6KB1AKT1AKT1S1
SCHEMBL473448 0.80 ALDH1A1 (0.50) MEN1KMT2ALMNAKDM4EALDH1A1
SCHEMBL473341 0.79 PDE10A (0.45) MEN1KMT2ARAB9ACSF1RRPS6KB1
SCHEMBL473395 0.79 RECQL (0.54) MEN1KMT2ALMNAKDM4EALDH1A1
SCHEMBL473325 0.79 LMNA (0.56) MEN1KMT2ACSF1RRPS6KB1AKT1
SCHEMBL10158974 0.79 CSF1R (0.39) MEN1KMT2ARAB9ACSF1RRPS6KB1
SCHEMBL1795146 0.79 TTR (0.53) LIMK2RPS6KB1AKT1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1848719-B1 [1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YL]-PIPERIDINE OR -PIPERAZINE COMPOUNDS AS SERINE-THREONINE KINASE MODULATORS (P70S6K, ATK1 AND ATK2) FOR THE TREATMENT OF IMMUNOLOGICAL, INFLAMMATORY AND PROLIFERATIVE DISEASES EXELIXIS INC (US) 2012-02-01 EP disclosed